Webinar
on demand
30
Jan
2023
17
00
CET
Tumour sites
Interstitial Lung Disease (ILD): a rare but severe side-effect

This session is part of the SPCC Adverse Events Management and Interstitial Lung Disease (ILD) Detection Project. Following the Task Force - held in 2022 - the fourth phase of the project will focus on the results emerged from the discussion on the new strategies to tackle adverse events on Interstitial Lung Disease Cancer.

 

 

Speakers
Discussant
Rugo Hope
Division of Hematology and Oncology at the University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, San Francisco, USA
Expert
Addeo Alfredo
Oncology Division, University Hospital Geneva, Geneve, Switzerland
Expert
Bergeron Anne
Pneumology Dept., Hôpitaux Universitaires Genève, Geneva, Switzerland
Expert
Senan Suresh
Amsterdam University Medical Centers, VUmc location, Amsterdam, The Netherlands
Login for the Webinar Programme
This material is part of Educational Project:
2022 - Adverse Events Management and Interstitial Lung Disease (ILD) Detection Project